CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 32 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,757,655 | +18.3% | 148,261 | -18.4% | 0.57% | +12.6% |
Q3 2022 | $2,332,000 | -2.1% | 181,799 | -46.5% | 0.51% | -12.9% |
Q2 2022 | $2,383,000 | -21.3% | 339,942 | -7.0% | 0.58% | +3.2% |
Q1 2022 | $3,029,000 | +87.1% | 365,415 | +52.8% | 0.56% | +112.0% |
Q4 2021 | $1,619,000 | -36.4% | 239,071 | -52.1% | 0.27% | -57.4% |
Q1 2019 | $2,544,000 | -17.7% | 498,844 | -36.9% | 0.62% | +12.6% |
Q4 2017 | $3,092,000 | +1589.6% | 790,872 | +1199.5% | 0.55% | +1810.3% |
Q3 2015 | $183,000 | -80.8% | 60,858 | -73.7% | 0.03% | -74.1% |
Q2 2015 | $954,000 | -5.1% | 231,051 | -0.5% | 0.11% | -3.4% |
Q1 2015 | $1,005,000 | -26.3% | 232,176 | -48.1% | 0.12% | -57.4% |
Q3 2013 | $1,363,000 | – | 446,957 | – | 0.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |